Deutsche Bank Starts ViroPharma (VPHM) at Buy; Sees 30%+ EPS Growth
Tweet Send to a Friend
Deutsche Bank initiates coverage on ViroPharma (NASDAQ: VPHM) with a Buy. PT $37.00.
The firm comments, "Viropharma belongs to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm comments, "Viropharma belongs to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
